Presentation
Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. 10th Annual Rheumatology Winter Clinical Symposium (RWCS), Maui, Hawaii, Feb 2017.
10th Annual Rheumatology Winter Clinical Symposium (RWCS)
(2017)
Disciplines
Publication Date
February, 2017
Citation Information
Philip Mease and et.al.. "Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. 10th Annual Rheumatology Winter Clinical Symposium (RWCS), Maui, Hawaii, Feb 2017." 10th Annual Rheumatology Winter Clinical Symposium (RWCS) (2017) Available at: http://works.bepress.com/philip-mease/295/